{"referenced_tweets": [{"type": "replied_to", "id": "1268656349510066178"}], "possibly_sensitive": false, "entities": {"hashtags": [{"start": 31, "end": 50, "tag": "Hydroxychloroquine"}, {"start": 159, "end": 167, "tag": "Covid19"}, {"start": 168, "end": 178, "tag": "GlobalWar"}, {"start": 179, "end": 184, "tag": "NEJM"}, {"start": 185, "end": 189, "tag": "NYC"}], "mentions": [{"start": 0, "end": 8, "username": "CBCNews", "id": "6433472"}, {"start": 78, "end": 83, "username": "NEJM", "id": "25950355"}], "urls": [{"start": 135, "end": 158, "url": "https://t.co/1uY9l5ONgT", "expanded_url": "https://www.nejm.org/doi/full/10.1056/NEJMoa2016638", "display_url": "nejm.org/doi/full/10.10\u2026"}]}, "reply_settings": "everyone", "in_reply_to_user_id": "6433472", "created_at": "2020-06-05T03:40:05.000Z", "text": "@CBCNews Court is still out on #Hydroxychloroquine  double blind study \ud83d\udcd6 from @NEJM found little benefit with risk of side effects -)  https://t.co/1uY9l5ONgT #Covid19 #GlobalWar #NEJM #NYC", "lang": "en", "public_metrics": {"retweet_count": 0, "reply_count": 0, "like_count": 0, "quote_count": 0}, "source": "Twitter for iPhone", "author_id": "239000080", "conversation_id": "1268656349510066178", "id": "1268749406699835392", "context_annotations": [{"domain": {"id": "47", "name": "Brand", "description": "Brands and Companies"}, "entity": {"id": "1105110947335593985", "name": "CBC", "description": "CBC"}}, {"domain": {"id": "123", "name": "Ongoing News Story", "description": "Ongoing News Stories like 'Brexit'"}, "entity": {"id": "1220701888179359745", "name": "COVID-19"}}]}